Latest Research Reports

UK and Australian health authorities disagree over E-cigarettes

UK and Australian health authorities disagree over E-cigarettes

Detecting AML subtype the key to better targeted drugs

Detecting AML subtype the key to better targeted drugs

The growing burden of ART-resistant HIV

The growing burden of ART-resistant HIV

Surge in deals promises a brighter future for fatty liver disease

Deals involving drugs to treat fatty liver disease (FLD) hit an all-time high in 2016, with more than twice as many completed as in any year...

Surge in deals promises a brighter future for fatty liver disease

Non-profit licensing deal values climb in 2016

In 2016, there was a surge in deal values between the biopharmaceutical industry and non-profit...

Non-profit licensing deal values climb in 2016

Non-alcoholic steatohepatitis cases expected to nearly double over next decade

Non-alcoholic steatohepatitis (NASH) is a common, often clinically silent liver disease characterized by the presence of fat in the liver, in addition to liver inflammation and...

Non-alcoholic steatohepatitis cases expected to nearly double over next decade

Report: French pharmaceutical market to witness negative compound annual growth rate of 1% by 2021

The French pharmaceuticals market is projected to decline from $35.5bn in 2017 to $34.16bn in 2021, according to a report by...

Report: French pharmaceutical market to witness negative compound annual growth rate of 1% by 2021

NSCLC incidence continues to increase in urban China

Lung cancer has become the most common cancer in China. GlobalData’s epidemiology forecast for non-small cell lung cancer (NSCLC),...

NSCLC incidence continues to increase in urban China

Asia's growing burden of an ageing population and colorectal cancer

Recent cancer surveillance data shows that in the past decade, Asian countries such as China and Japan have experienced an increase in new cases of colorectal cancer (CRC)....

Asia's growing burden of an ageing population and colorectal cancer

Report: Japanese pharmaceutical market to witness moderate growth up to 2021

The Japanese pharmaceutical market is forecast to moderately increase from $70bn in 2016 to $72bn by 2021, according to a report by...

Report: Japanese pharmaceutical market to witness moderate growth up to 2021

Biosimilars put top selling cancer drug under threat

The recent European Medicines Agency (EMA) approval of the first rituximab biosimilar has placed a top selling cancer drug, Roche’s Rituxan/Mabthera (rituximab), under...

Biosimilars put top selling cancer drug under threat

VTE: too many at-risk patients are not being treated

Venous thromboembolism (VTE), which comprises of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a blood clot (thrombosis) of the circulatory system that blocks blood flow. VTE...

VTE: too many at-risk patients are not being treated

Drivers for the next decade of diabetic foot ulcer drug sales

The ever-increasing prevalence of diabetes, along with the anticipated launch of a novel wound healing agent, will lead to significant growth of the US Diabetic Foot Ulcer (DFU) market through...

Drivers for the next decade of diabetic foot ulcer drug sales

Surge of bladder cancer in Japan - a consequence of population aging?

Bladder cancer is one of the most common cancers worldwide. Historically, it is most frequent in Western countries and lowest in Asian...

Surge of bladder cancer in Japan - a consequence of population aging?

Big Data will impact many pharmaceutical sectors over the next five years

GBI Research’s recent publication [hyperlink] examines how Big Data technologies can be used to transform commercial strategy and provide competitive advantage....

Big Data will impact many pharmaceutical sectors over the next five years

Can tanezumab provide safer and more effective treatment for cancer pain management?

More than half of all cancer patients experience pain as a result of their cancer, current treatment options are lacking and can leave patients suffering with chronic pain, which can...

Can tanezumab provide safer and more effective treatment for cancer pain management?

Report: Tauopathies market projected to grow with launch of first-to-market drug

The tauopathies market is expected to be driven by the launch of a first-to-market drug, says a report by...

Report: Tauopathies market projected to grow with launch of first-to-market drug

US to see growth in diagnosed prevalence of primary hyperparathyroidism

Improved diagnosis rates may contribute to increase in...

US to see growth in diagnosed prevalence of primary hyperparathyroidism

Report: Global hepatitis C market to witness negative compound annual growth rate of 2.1% by 2025

The hepatitis C market is projected to decline from $21.7bn in 2015 to $17.5bn by 2025, according to a report by...

Report: Global hepatitis C market to witness negative compound annual growth rate of 2.1% by 2025

Can vaccines treat colorectal cancer effectively with no side effects?

Colorectal cancer (CRC) is the third most common type of cancer in the US, and its treatment is often associated with severe side...

Can vaccines treat colorectal cancer effectively with no side effects?

Improved diagnosis will increase number of patients seeking psoriatic arthritis treatment

Psoriatic arthritis (PsA) is a type of inflammatory joint disease that may get worse over time, resulting in severe joint damage and disability....

Improved diagnosis will increase number of patients seeking psoriatic arthritis treatment